期刊文献+

溶致液晶递药系统的研究进展

Research progress on lyotropic liquid crystal drug delivery systems
暂未订购
导出
摘要 溶致液晶(LLC)是由两亲性分子在特定溶剂条件下自组装而成的特殊液晶,作为一种新型药物递送系统,形成的层状相、六角相和立方相等液晶相结构,具有热力学稳定体系,高效包载药物分子和控释的优势。在皮下注射、静脉给药、局部及口服递送中,LLC通过形成药物储库、延长滞留时间、提高生物利用度及靶向性,显著改善治疗效果。本文综述近年来LLC递药系统的研究进展,并重点阐述其液晶相结构与晶型特征、载体材料选择、表征方法及其在药物递送中的应用,旨在为新型药物递送系统的开发提供理论依据和参考。 Lyotropic liquid crystals(LLC)are a class of liquid crystals that are formed through self-assembly of amphiphilic moleculesin a specific solvent environment.They have been identified as a novel delivery system for pharmaceuticals.The resultant layered,hexagonal and cubic phases exhibit thermodynamic stability and high loading capacity for pharmaceutical molecules,as well as the ability to control release.The use of LLCs in subcutaneous injection,intravenous administration,topical,and oral delivery has been shown to significantly enhance treatment outcomes.This review first briefly describes the research progress of LLC drug delivery systems in recent years,and focuses on its liquid crystal phase structure and crystal characteristics,carrier material selection,characterization methods,and application in drug delivery,so as to provide theoretical basis and reference for the development of new drug delivery systems.
作者 李景 贺洁 白文静 刘广瑞 韩笑 金牮 LI Jing;HE Jie;BAI Wenjing(Jiangsu Key Laboratory of Marine Pharmaceutical Compound Screening/School of Pharmacy,Jiangsu Ocean University,Lianyungang,Jiangsu 222000,China)
出处 《中国处方药》 2026年第2期122-126,共5页 Journal of China Prescription Drug
关键词 溶致液晶 药物递送 长效 晶型 载体 Lyotropic liquid crystals Drug delivery Long-acting Crystal form Carrier
  • 相关文献

参考文献6

二级参考文献77

  • 1王志宁,郑利强,李干佐.蔗糖对MO/水立方液晶体系流变性质的影响[J].化学学报,2005,63(4):274-278. 被引量:15
  • 2王志宁,郑利强.类脂立方液晶作为药物载体的研究[J].化学进展,2005,17(3):417-422. 被引量:17
  • 3Muller F, Salonen A, Glatter O. Monoglyceride-based cubosomes stabilized by Laponite:Separating the effects of stabilizer, pH and temperature [J]. Colloids Surf A Physicochem Eng Asp ,2010,358( 1/3 ) :50-56.
  • 4Sallam A S, Khalil E, Ibrahim H, et al. Formulation of an oral dosage form utilizing the properties of cubic liquid crystalline phases of glyceryl monooleate [ J ]. Eur J Pharm Biopharm,2002,53 ( 3 ) :343-352.
  • 5Amar-Yuli I, Wachtel E, Shalev D E,et al. Low viscosity reversed hexagonal mesophases induced by hydrophilic additives [ J ]. J Phys Chem B, 2008, 112 (13):3971-3982.
  • 6Libster D, Aserin A, Garti N. Interactions of biomacromo-lecules with reverse hexagonal liquid crystals : drug delivery and crystallization applications [ J ]. J Colloid Interface Sci,2011,356( 2 ) :375-386.
  • 7Shah M H, Paradkar A. Effect of HLB of additives on the properties and drug release from the glyceryl monooleate matrices [ J ]. Eur J Pharm Biopharm, 2007,67 ( 1 ) : 166-174.
  • 8Mulet X,Kennedy D F, Conn C E,et al. High throughput preparation and characterisation of amphiphilic nanostructured nanoparticulate drug delivery vehicles [ J ]. lnt J Pharm ,2010,395 ( 1/2 ) :290-297.
  • 9Lee K W, Nguyen T H, Hanley T,et al. Nanostrueture of liquid crystalline matrix determines in vitro sustained release and in vivo oral absorption kinetics for hydrophilic model drugs [ J ]. Int J Pharm, 2009,365 ( 1/2 ) : 190-199.
  • 10Cervin C, Tinzl M, Johnsson M, et al. Properties and effects of a novel liquid crystal nanoparticle formulation of docetaxel in a prostate cancer mouse model [ J ]. Eur J Pharm Sci ,2010,41 (2) :369-375.

共引文献15

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部